top of page

VAMINOLACT INTRAVENOUS SOLUTION

Product details

Registration number: SIN07428P

Classification: General Sale List

Active ingredients:

  • ALANINE
  • ARGININE
  • ASPARTIC ACID
  • CYSTEINE
  • GLUTAMIC ACID
  • GLYCINE
  • HISTIDINE
  • ISOLEUCINE
  • LEUCINE
  • LYSINE
  • METHIONINE
  • PHENYLALANINE
  • PROLINE
  • SERINE
  • TAURINE
  • THREONINE
  • TRYPTOPHAN
  • TYROSINE
  • VALINE

Strength:

  • 6.3 g/1000 ml
  • 4.1 g/1000 ml
  • 4.1 g/1000 ml
  • 1 g/1000 ml
  • 7.1 g/1000 ml
  • 2.1 g/1000 ml
  • 2.1 g/1000 ml
  • 3.1 g/1000 ml
  • 7 g/1000 ml
  • 5.6 g/1000 ml
  • 1.3 g/1000 ml
  • 2.7 g/1000 ml
  • 5.6 g/1000 ml
  • 3.8 g/1000 ml
  • 300 mg/1000 ml
  • 3.6 g/1000 ml
  • 1.4 g/1000 ml
  • 500 mg/1000 ml
  • 3.6 g/1000 ml

Dosage form: INJECTION

Route: INTRAVENOUS

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

ATC code: B05BA01

HSA approval date: 12 May 1993

Manufacturer(s): FRESENIUS KABI AUSTRIA GMBH

Manufacturing country/countries: AUSTRIA

What are the HSA registration number and classification for VAMINOLACT INTRAVENOUS SOLUTION?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN07428P

Classification: General Sale List

Source for this answer

What active ingredients and strength are recorded for VAMINOLACT INTRAVENOUS SOLUTION?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • ALANINE
  • ARGININE
  • ASPARTIC ACID
  • CYSTEINE
  • GLUTAMIC ACID
  • GLYCINE
  • HISTIDINE
  • ISOLEUCINE
  • LEUCINE
  • LYSINE
  • METHIONINE
  • PHENYLALANINE
  • PROLINE
  • SERINE
  • TAURINE
  • THREONINE
  • TRYPTOPHAN
  • TYROSINE
  • VALINE

Strength:

  • 6.3 g/1000 ml
  • 4.1 g/1000 ml
  • 4.1 g/1000 ml
  • 1 g/1000 ml
  • 7.1 g/1000 ml
  • 2.1 g/1000 ml
  • 2.1 g/1000 ml
  • 3.1 g/1000 ml
  • 7 g/1000 ml
  • 5.6 g/1000 ml
  • 1.3 g/1000 ml
  • 2.7 g/1000 ml
  • 5.6 g/1000 ml
  • 3.8 g/1000 ml
  • 300 mg/1000 ml
  • 3.6 g/1000 ml
  • 1.4 g/1000 ml
  • 500 mg/1000 ml
  • 3.6 g/1000 ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for VAMINOLACT INTRAVENOUS SOLUTION?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for VAMINOLACT INTRAVENOUS SOLUTION?

According to the HSA dataset updated 7 August 2026:

Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for VAMINOLACT INTRAVENOUS SOLUTION?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): FRESENIUS KABI AUSTRIA GMBH

Manufacturing country/countries: AUSTRIA

Source for this answer

Where can I look up VAMINOLACT INTRAVENOUS SOLUTION in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN07428P or the exact product name VAMINOLACT INTRAVENOUS SOLUTION. The general register link does not preselect this product.

Source for this answer

What are the source dates for this VAMINOLACT INTRAVENOUS SOLUTION record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this VAMINOLACT INTRAVENOUS SOLUTION record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN07428P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page